Cognito’s wearable device boosts brain proteins linked to Alzheimer’s protection

Cognito Therapeutics will present new data at the Alzheimer’s Association International Conference (AAIC) 2026 in London showing the effects of its investigational device Spectris on lipid transport biomarkers in Alzheimer’s disease. The poster Spectris Sensory Stimulation Increases CSF HDL-like Lip…

View Post on Scour ↗

More from longevity.technology on Scour.